Mineralys Therapeutics, Correlations
MLYS Stock | 14.28 0.72 4.80% |
The current 90-days correlation between Mineralys Therapeutics, and Zumiez Inc is 0.07 (i.e., Significant diversification). The correlation of Mineralys Therapeutics, is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Mineralys Therapeutics, Correlation With Market
Very good diversification
The correlation between Mineralys Therapeutics, Common and DJI is -0.22 (i.e., Very good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Mineralys Therapeutics, Common and DJI in the same portfolio, assuming nothing else is changed.
Mineralys |
Moving against Mineralys Stock
0.75 | WMT | Walmart | PairCorr |
0.55 | OCEAW | Ocean Biomedical | PairCorr |
0.53 | MLSS | Milestone Scientific | PairCorr |
0.46 | CDIOW | Cardio Diagnostics | PairCorr |
0.44 | CMND | Clearmind Medicine Common | PairCorr |
0.34 | ASMB | Assembly Biosciences | PairCorr |
0.33 | ABUS | Arbutus Biopharma Corp | PairCorr |
0.33 | SCLX | Scilex Holding | PairCorr |
0.77 | HD | Home Depot | PairCorr |
0.72 | DIS | Walt Disney | PairCorr |
0.66 | JPM | JPMorgan Chase | PairCorr |
0.41 | MSFT | Microsoft | PairCorr |
0.39 | CAT | Caterpillar | PairCorr |
0.36 | CSCO | Cisco Systems Aggressive Push | PairCorr |
0.31 | BA | Boeing | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Mineralys Stock performing well and Mineralys Therapeutics, Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Mineralys Therapeutics,'s multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
ZUMZ | 2.34 | (0.24) | 0.00 | (0.17) | 0.00 | 5.72 | 16.30 | |||
TSN | 1.00 | 0.12 | 0.11 | 0.58 | 1.13 | 2.49 | 5.57 | |||
LE | 2.41 | (0.19) | 0.00 | (0.13) | 0.00 | 4.90 | 24.25 | |||
RBC | 1.20 | 0.13 | 0.10 | 0.13 | 1.23 | 3.35 | 11.50 | |||
GFF | 1.50 | 0.06 | 0.02 | 0.01 | 1.62 | 2.86 | 12.51 | |||
GIL | 1.16 | (0.04) | 0.00 | (0.07) | 0.00 | 2.54 | 8.64 | |||
JRSH | 0.96 | 0.06 | 0.06 | 1.34 | 1.12 | 1.65 | 11.86 |
Mineralys Therapeutics, Corporate Management
Robert McKean | Senior CMC | Profile | |
Sarah Foster | Vice Resources | Profile | |
Danielle Bradbury | Senior Assurance | Profile | |
Cindy Berejikian | Executive Operations | Profile | |
Minji MBA | Chief Officer | Profile |